Literature DB >> 346284

Interrelationship between renal haemodynamics, drug kinetics and drug action.

K L Duchin, R W Schrier.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 346284     DOI: 10.2165/00003088-197803010-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  52 in total

1.  Pharmacokinetics of drugs in patients with the nephrotic syndrome.

Authors:  R Gugler; D W Shoeman; D H Huffman; J B Cohlmia; D L Azarnoff
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin.

Authors:  E T Schroeder; L Shear; S M Sancetta; G J Gabuzda
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

3.  Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors:  I Odar-Cederlöf; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 4.  Drug protein binding and the nephrotic syndrome.

Authors:  R Gugler; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 5.  Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators.

Authors:  N K Hollenberg; D F Adams; H Solomon; W R Chenitz; B M Burger; H L Abrams; J P Merrill
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

Review 6.  Renal failure, drug pharmacokinetics and drug action.

Authors:  J Fabre; L Balant
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 7.  Pharmacokinetics and response to diazoxide in renal failure.

Authors:  R M Pearson
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

8.  Renal function, protein binding and pharmacological response to diazoxide.

Authors:  R M Pearson; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

9.  Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole.

Authors:  W M Bennett; R Craven
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

10.  Renal tubular handling of drugs.

Authors:  E J Cafruny
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

View more
  8 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  Physiological modelling of renal drug clearance.

Authors:  I Janků
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Measurement of the renal clearance of drugs.

Authors:  G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

Review 5.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

7.  The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.

Authors:  K J Hoffmann; C G Regårdh; M Aurell; M Ervik; L Jordö
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

8.  Differential effects of anesthetic regimens on gentamicin pharmacokinetics in the rat: a comparison with chronically catheterized conscious animals.

Authors:  M Gumbleton; P J Nicholls; G Taylor
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.